Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas

BRUSSELS--14 Dec--PRNewswire-AsiaNet/InfoQuest


- Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries

- A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season

- Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food, writing cards and wrapping presents most difficult to do

- Nearly two thirds of women living with rheumatoid arthritis experience pain daily

A global survey reveals that rheumatoid arthritis (RA) has a severe emotional and physical impact on people living with the disease and their families. Feelings of detachment and isolation from those closest to them due to RA are especially prevalent at Christmas, which should be one of the happiest times of the year. The survey findings of 1,958 women with RA from seven countries worldwide, suggest that 35% of women living with RA feel the disease impacts on their enjoyment of family events during the festive season.

The survey, sponsored by biopharmaceutical company UCB, highlights that 23% of women living with RA find it always painful, more difficult or have stopped attending parties or celebrations due to their condition, and 44% of women with moderate to severe RA report they don't enjoy family events such as Christmas as much as they used to. Even amongst young women (25 - 35 year olds), 28% feel their enjoyment of family events is restricted due to their RA.

Personal relations are also impacted by RA with one third of women believing the condition affects their closest relationships for the worse, and more than half feel that friends and family do not understand their pain. "The holidays are an occasion to spend fun quality time with family and friends, not a period for anxiety due to busy schedules, social gatherings, and the pain associated with over activity. However, for many women living with RA this isolation and pain is a common feeling," said Dr. Vibeke Strand, Adjunct Clinical Professor, Division of Immunology/Rheumatology of Stanford University School of Medicine. "More often, many prefer to hide their degree of pain and discomfort from family and friends to avoid hindering the festive

celebrations which can lead to a feeling of isolation."

Daily pain is an issue - 63% of respondents live with pain - this can be exacerbated by the dexterity needed for even the simplest of Christmas tasks which is illuminated by the survey with 28% of moderate to severe RA respondents always experiencing pain, find it more difficult or have stopped writing cards altogether.

Shopping for gifts, preparing food, writing cards and wrapping presents are the four festive activities that women living with RA find most difficult to do. Among these women, 28% experience pain and difficulty when shopping for gifts, or have stopped altogether, and more than a quarter report it painful to prepare festive food.

"Nearly two thirds of women living with RA experience pain every day which can be more intense during busy times of the year, such as Christmas and this can seriously impact a patient's enjoyment of the festive season. Almost half of patients included in the survey are not talking to their physician about pain control options which is imperative to enable them to take control of their pain, especially around Christmas when pain can be a considerable issue. This will ensure that more patients achieve a pain free 'good day' and ultimately improve their quality of life." Said Professor Paul Emery, Professor of Rheumatology, University of Leeds.

In light of these survey findings UCB has developed the "12 Tips of Christmas" with tips on how to manage and enjoy the hectic holiday season. For further information and the "12 Tips of Christmas" please email [email protected] for the full guide that details ways to embrace and enjoy the countdown to Christmas.

About the 'Good Days' Survey

The 'Good Days' Survey was conducted in August 2009 as part of a global initiative assessing the lifestyles of women with rheumatoid arthritis in seven major industrialized countries: Canada, France, Germany, Italy, Spain, the United Kingdom, and the United States. Objectives of the Survey included identification of the physical and emotional impact of RA on day-to-day lives of women living with the disease. A component of the Survey examined the affects of the disease on people living with RA during the festive season. Nearly 2,000 women aged between 25-65 years living with RA for six months or more were interviewed online about the impact of the disease on their lives.

About Rheumatoid Arthritis

It is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.

RA symptoms often lead to restricted mobility and permanent damage and disfigurement of the joints and bones. People living with RA are at a higher risk of developing other conditions, including heart disease, stroke, depression, infections, lung problems and osteoporosis.

About UCB

UCB, Brussels, Belgium (http://www.ucb.com) is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 10,000 people in over 40 countries, UCB generated revenue of EUR 3.6 billion in 2008. UCB is listed on Euronext Brussels (symbol: UCB).

SOURCE: UCB

--Distributed by AsiaNet ( www.asianetnews.net )--


ข่าวrheumatoid arthritis+o:healวันนี้

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf(R) in Taiwan and select South-East Asian markets

Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf(R) 50 mg and 100 mg Tablets (generic name: peficitinib hydrobromide) in Taiwan for the treatment of rheumatoid arthritis. Smyraf(R) has been approved in Taiwan and has patent protection for composition of matter until 2032. Subject to the terms of the

Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases

- Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis -...

Zydus Launches World’s First Biosimilar of Adalimumab

Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing Spondylitis in India After more than a decade-long wait, the...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)

Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business Coherus BioSciences, Inc. announced the start of its...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an...

Yok Chinese Restaurant of the Emerald Hot... “Marinated shredded chicken with jelly fish served cold” @ Yok Chinese Restaurant — Yok Chinese Restaurant of the Emerald Hotel would like to invite you t...

Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

- Phase II Study Published in the New England Journal of Medicine AstraZeneca's (LSE: AZN) new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel...

Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas

- Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries - A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of...

Asian Countries Cannot Afford To Ignore the Cost of Rheumatoid Arthritis

- Early Diagnosis and Treatment for Patients with Rheumatoid Arthritis Urgently Needed to Relieve Social, Economic and Personal Disease Burden - - New Initiative Launched to Highlight the Need to Reassess Treatment Approaches in...

ฮูไมร่า (HUMIRA)(R) (adalimumab) ของแอ๊บบอตได้รับการยกย่องจากรางวัล กาเลน ไพรซ์ว่า เป็นนวัตกรรมในการรักษาผู้ป่วย

พริกซ์ กาเลียน จากสหรัฐอเมริกา ยกย่องให้ฮูไมร่าเป็นสินค้าเทคโนโลยีชีวภาพที่ดีที่สุด แอ๊บบอต (NYSE: ABT) ผู้นำในการรักษาโรคเกี่ยวกับภูมิคุ้มกันอัตโนมัติ ได้รับรางวัลกาเลน ไพรซ์ ปี 2007 ...